ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 693547 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 693547; 2) Community: the network communities that were significantly associated with the response to NSC 693547; 3) Molecule: the relationships between components within communities and NSC 693547; 4) MDR: the compounds that were significantly associated with the NSC 693547.

NSC Compound Enrichment Correlation
NSC 668296 Null 0.0179905510964915 0.39298935
NSC 668494 Null 0.0179905510964915 0.40188865
NSC 67588 2-Naphthacenecarboxamide, 4-dimethylamino-1,4,4a,5,5a,6,11,12a-pentahydroxy-N-[6-mercaptopurin-7(or 9)-ylmethyl]-6-methyl-1,11-dioxo- 0.0179905510964915 0.22367496
NSC 686557 Null 0.0179905510964915 0.38522015
NSC 709974 Null 0.0186186224062458 0.35914598
NSC 715407 Null 0.0186186224062458 0.43375575
NSC 718781 Erlotinib hydrochloride 0.0186186224062458 -0.22415134
NSC 719667 7-methoxy-8-[3-(1,4-oxazinan-4-yl)propoxy-(11aS)-2,3,5,11a -tetrahydro-1H-pyrrolo[2,1-c][1,4]benzodiazepine-5-one 0.0186186224062458 0.37048954
NSC 720320 1,6-bis-(2,6-difluorobenzyl)-2-(2,6-difluorophenyl)-5-methoxy-benzimidazole 0.0186186224062458 0.046549034
NSC 724783 [1,5-dimethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetra cyclo[10.3.1.04,13.08,13]hexadec-9-en-9-yl]-N,N-bis{[1,5-dim ethyl-10-(trifluoromethyl)-11,14,15,16-tetraoxatetracyclo[10 .3.1.04,13.08,13 0.0186186224062458 0.23653361
Total:147  Current:79    [First] [Prev] [Next] [Last]